Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SUM229PE | TNBC | - | Mebendazole | 0.107 | uM | 13009.174 | 0.8455 | 0.7756 | 1.4104 | |||
| SUM229PE | TNBC | - | Mebendazole | 0.533 | uM | 13009.174 | 0.5672 | 0.3380 | 1.4104 | |||
| SUM229PE | TNBC | - | Mebendazole | 2.67 | uM | 13009.174 | 0.3593 | -0.0320 | 1.4104 | |||
| SUM229PE | TNBC | - | Mebendazole | 13.3 | uM | 13009.174 | 0.3690 | -0.0137 | 1.4104 | |||
| SUM229PE | TNBC | - | Mebendazole | 66.7 | uM | 13009.174 | 0.4658 | 0.1635 | 1.4104 | |||
| SUM229PE | TNBC | - | Mebendazole | 0.000171 | uM | 13062.174 | 0.9861 | 0.9833 | 1.6688 | |||
| SUM229PE | TNBC | - | Mebendazole | 0.000853 | uM | 13062.174 | 0.9654 | 0.9582 | 1.6688 | |||
| SUM229PE | TNBC | - | Mebendazole | 0.00427 | uM | 13062.174 | 0.9621 | 0.9542 | 1.6688 | |||
| SUM229PE | TNBC | - | Mebendazole | 0.0213 | uM | 13062.174 | 0.9788 | 0.9745 | 1.6688 | |||
| SUM229PE | TNBC | - | Mebendazole | 0.107 | uM | 13062.174 | 0.9372 | 0.9238 | 1.6688 | |||
| SUM229PE | TNBC | - | Mebendazole | 0.533 | uM | 13062.174 | 0.7481 | 0.6808 | 1.6688 | |||
| SUM229PE | TNBC | - | Mebendazole | 2.67 | uM | 13062.174 | 0.7777 | 0.7203 | 1.6688 | |||
| SUM229PE | TNBC | - | Mebendazole | 13.3 | uM | 13062.174 | 0.7400 | 0.6699 | 1.6688 | |||
| SUM229PE | TNBC | - | Mebendazole | 66.7 | uM | 13062.174 | 0.4859 | 0.2977 | 1.6688 | |||
| SUM52PE | HR+ | Luminal | Mebendazole | 0.000171 | uM | 12969.174 | 0.9256 | 0.8665 | 1.1194 | |||
| SUM52PE | HR+ | Luminal | Mebendazole | 0.000853 | uM | 12969.174 | 0.9291 | 0.8728 | 1.1194 | |||
| SUM52PE | HR+ | Luminal | Mebendazole | 0.00427 | uM | 12969.174 | 1.0579 | 1.1031 | 1.1194 | |||
| SUM52PE | HR+ | Luminal | Mebendazole | 0.0213 | uM | 12969.174 | 0.9811 | 0.9662 | 1.1194 | |||
| SUM52PE | HR+ | Luminal | Mebendazole | 0.107 | uM | 12969.174 | 0.8003 | 0.6391 | 1.1194 | |||
| SUM52PE | HR+ | Luminal | Mebendazole | 0.533 | uM | 12969.174 | 0.6396 | 0.3417 | 1.1194 | |||
| SUM52PE | HR+ | Luminal | Mebendazole | 2.67 | uM | 12969.174 | 0.6443 | 0.3505 | 1.1194 | |||
| SUM52PE | HR+ | Luminal | Mebendazole | 13.3 | uM | 12969.174 | 0.5923 | 0.2527 | 1.1194 | |||
| SUM52PE | HR+ | Luminal | Mebendazole | 66.7 | uM | 12969.174 | 0.5061 | 0.0884 | 1.1194 | |||
| SUM52PE | HR+ | Luminal | Mebendazole | 0.000171 | uM | 13570.174 | 0.9424 | 0.7841 | 0.5197 | |||
| SUM52PE | HR+ | Luminal | Mebendazole | 0.000853 | uM | 13570.174 | 0.8822 | 0.5714 | 0.5197 |